DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
DoW Pancreatic Cancer Research Program, Translational Research Partnership Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was October 7, 2026. Total estimated funding is $6.6M across about 6 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- May 4, 2026Posted
- Oct 7, 2026Application deadline
- Nov 6, 2026Archivednext date
- Posted
- May 4, 2026
- Close date
- Oct 7, 2026
- Archive date
- Nov 6, 2026
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $6,600,000
- Implied average award
- $1,100,000 calculated
- Expected awards
- 6
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Translational Research Partnership Award supports partnerships between clinicians, population scientists, applied scientists and/or basic scientists that will accelerate the movement of promising ideas in pancreatic cancer toward clinical applications. The partnership must include at least one member with expertise in pancreatic cancer research or pancreatic cancer patient care. All applications must address at least one of the FY26 PCARP Focus Areas.
· This award mechanism requires preliminary data to support feasibility of the research hypothesis(es) and research approaches. However, these data do not necessarily need to originate from studies of pancreatic cancer. Applications can support retrospective tissue analysis, correlative studies and pilot clinical trials; however, this mechanism does not allow large-scale clinical trials.
· The Translational Research Partnership Award requires two Principal Investigators (PIs) referred to as the Initiating PI and the Partnering PI. Only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
Assistance Listing
What is an ALN?Reported obligations under ALN 12.420
Historical data · not a predictionWho was funded under ALN 12.420
Historical data · not a predictionSince October 1, 2023, 6,147 grant awards had funding actions under Military Medical Research and Development, with 2,218 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.$139M
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER$118M
- REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE$81.8M
- THE JOHNS HOPKINS UNIVERSITY$72.4M
- UNIVERSITY OF CALIFORNIA, LOS ANGELES$62.2M
Agency contact (as published)
Jamie Shortall Grant Officer
help@eBRAP.org
301-619-2393
Quick answers
Who is eligible to apply for “DoW Pancreatic Cancer Research Program, Translational Research Partnership Award”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through “DoW Pancreatic Cancer Research Program, Translational Research Partnership Award”?
Per the notice, total estimated program funding is $6,600,000 and the agency expects to make about 6 awards.
How do I apply for “DoW Pancreatic Cancer Research Program, Translational Research Partnership Award”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526PCARPTRPA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DoW Traumatic Brain Injury and Psychological Health, Translational Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 15, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Military Burn, Discovery Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 21, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Autism Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Arthritis Translational Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Reconstructive Transplant, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 4, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Bone Marrow Failure, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 4, 2026
- Who can apply
- Unrestricted (any entity type)